Biostrap

Clinical-grade wearable biosensor data

Los Angeles, California, US

Biostrap is a precision health monitoring company offering a wearable health platform and remote patient monitoring solutions. It provides objective, 24/7 medical-grade measurements of physiological and behavioral data from a patient's home, utilizing high-resolution, raw biosensor data for digital biomarkers.

Shareable draft

Check out Biostrap on @MedStartr Today Biostrap is a precision health monitoring company offering a wearable health platform and remote patient monitoring solutions. It provides objective, 24/7 medical-grade measurements of physiological and behavioral data from a patient's home, utilizing high-resolution, raw biosensor data for digital biomarkers. #SickleCellDisease #COVID19 #ChronicDiseases #AutoimmuneDiseases #MyalgicEncephalomyelitisChronicFatigueSyndrome #CognitiveDecline #ChronicInflammatoryResponseSyndrome #CardiovascularDisease #ChronicPain #NeuromuscularDiseases #MyastheniaGravis #HypertrophicObstructiveCardiomyopathy #AlzheimerSDiseaseDementia #PTSDTrauma #HeartFailure #Depression #MultipleSclerosis #ObesityOverweight #MedicalDevices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/oSs-wG2kwng

Get Involved in Biostrap

How We Help

Problem Statement

Biostrap provides objective, 24/7 medical-grade measurements of physiological and behavioral data from a patient's home, utilizing high-resolution, raw biosensor data for digital biomarkers.

Core Technology

Wearable health platform, remote patient monitoring solutions, high-resolution raw biosensor data for digital biomarkers, Kairos wearable.

Key Differentiators

Objective, 24/7 medical-grade measurements; High-resolution, raw biosensor data for digital biomarkers; HIPAA-compliant web platform; Exceeded FDA's 3.5% RMSE requirement for SpO2 data capture

Company Info

Business Model: B2B SaaS
Website: biostrap.com

Disease Areas

Sickle Cell Disease COVID-19 Chronic Diseases Autoimmune Disease Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Cognitive Decline Chronic Inflammatory Response Syndrome Cardiovascular Disease Chronic Pain Neuromuscular Diseases Myasthenia Gravis Hypertrophic Obstructive Cardiomyopathy Alzheimer's & Dementia PTSD & Trauma Heart Failure Depression Multiple Sclerosis Obesity & Overweight

Technologies

BiosensorsDigital BiomarkersAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA Class II clearance for heart rate and respiratory rate (adjunctive); 22 clinical studies; 14 peer-reviewed publications; partnerships with Stanford, UCLA, NIH; selected by National Institute on Minority Health and Health Disparities for COVID-19 natural history study

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Biostrap?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.